enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  3. GSK shares fall after sales of top two vaccines disappoint - AOL

    www.aol.com/news/gsk-raises-annual-profit-sales...

    GSK would share additional data with U.S. agencies by the end of this year, she said. Citing the U.S. agency's decision, GSK cut its forecast for 2024 vaccine sales.

  4. GSK raises full-year profit forecast, says first-half will ...

    www.aol.com/news/gsk-raises-full-profit-forecast...

    The London-listed drugmaker said it now expects a rise of 8% to 10% in annual adjusted earnings per share, up from the 6%-9% growth previously forecast. It also expects its 2024 sales to rise in ...

  5. Andrew Witty - Wikipedia

    en.wikipedia.org/wiki/Andrew_Witty

    Andrew Witty. Sir Andrew Philip Witty (born 22 August 1964) [1] is a British business executive, who is the chief executive officer (CEO) of UnitedHealth Group. He was the CEO of GlaxoSmithKline between 2008 and 2017. He formerly held the role of chancellor of the University of Nottingham.

  6. GlaxoSmithKline Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/GlaxoSmithKline...

    india-pharma.gsk.com. GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4][5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology ...

  7. GSK CEO says RSV vaccine revenue to top 1 billion pounds in ...

    www.aol.com/news/gsk-ceo-says-rsv-vaccine...

    The U.S. Food and Drug Administration (FDA) approved Arexvy for adults aged 60 years or older in May and GSK launched the vaccine in the U.S. later in the year. It is also approved in Europe ...

  8. Haleon - Wikipedia

    en.wikipedia.org/wiki/Haleon

    Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12] In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]

  9. GSK's blood cancer drug meets primary goal in late-stage trial

    www.aol.com/news/gsk-says-blood-cancer-drug...

    Blenrep, which was the second-largest contributor to GSK's oncology business in 2022, has made about 30 million pounds ($37.38 million) in sales year-to-date. ($1 = 0.8025 pounds)